What is the uniqueness of the solutions that are being offered by start-up companies?
Start-ups need to have a unique value proposition if they want to survive and scale in the face of established companies in a space. By virtue of their DNA, which fosters nimbleness and a greater risk appetite, they have a better probability of being the powerhouses of innovative solutions.

What are some of the sectors where IIF will be contributing in the future?
IIF invests in the ICT and life sciences sectors. So our investments will include companies that have a strong technology offering in either of these domains. Going ahead, we may consider other sectors that have a strong technology component, like the cleantech sector.

How does IIF further plan to promote start-ups in the lucrative sector of the healthcare, life sciences, biotech and pharma?
What is important is that we use our strategic set of promoters, investors and their networks in order to provide strategic help before investing in a start-up firm. We are also looking to support the firms through mentoring and market access post investments. Not only is the success of our portfolio companies imperative to us, but we would also want to scaling up our support to a larger number of companies in these sectors. We want to and will make a significant impact in these sector.